Three-year follow-up of oral BG-12 (dimethyl fumarate) treatment in relapsing remitting multiple sclerosis (RRMS): integrated magnetic resonance imaging (MRI) outcomes from DEFINE, CONFIRM, and ENDORSE

被引：0
|
作者：
Miller, D. H. [1 ]
Fox, R. J. [2 ]
Gold, R. [3 ]
Havrdova, E. [4 ]
Kappos, L. [5 ]
MacManus, D. [1 ]
Yousry, T. [1 ]
Zhang, R.
Yang, M.
Viglietta, V.
Sheikh, S. I.
Dawson, K. T.
Arnold, D. L. [6 ,7 ]
机构：
[1] UCL, Inst Neurol, Queens Sq MS Ctr, London, England
[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[3] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[4] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[5] Univ Basel Hosp, Basel Neurol, CH-4031 Basel, Switzerland
[6] NeuroRx Res, Montreal, PQ, Canada
[7] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：461 / 462
页数：2
相关论文
共 50 条
  • [21] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated clinical efficacy data from DEFINE, CONFIRM, and the ENDORSE extension study
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Kappos, L.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    JOURNAL OF NEUROLOGY, 2014, 261 : S233 - S233
  • [22] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated clinical efficacy data from DEFINE, CONFIRM, and the ENDORSE extension study
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Kappos, L.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 344 - 344
  • [23] Effect of BG-12 (dimethyl fumarate) in newly diagnosed patients with relapsing-remitting multiple sclerosis from the DEFINE and CONFIRM studies
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    JOURNAL OF NEUROLOGY, 2013, 260 : S51 - S51
  • [24] CLINICAL AND NEURORADIOLOGICAL EFFECT OF BG-12 (DIMETHYL FUMARATE) IN SUBGROUPS OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS): AN INTEGRATED ANALYSIS OF THE PHASE 3 DEFINE AND CONFIRM STUDIES
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Miller, D. H.
    Arnold, D. L.
    O'Gorman, J.
    Yang, M.
    Sheikh, S., I
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    VALUE IN HEALTH, 2013, 16 (03) : A102 - A102
  • [25] Clinical and Neuroradiologic Efficacy of BG-12 (Dimethyl Fumarate) in US Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Kita, Mariko
    Fox, Robert
    Phillips, J. Theodore
    Arnold, Douglas
    Bar-Or, Amit
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine
    Viglietta, Vissia
    Sheikh, Sarah
    Gold, Ralf
    NEUROLOGY, 2013, 80
  • [26] Clinical Efficacy of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis (RRMS) According to Prior Therapy: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Hutchinson, Michael
    Gold, Ralf
    Fox, Robert
    Havrdova, Eva
    Giovannoni, Gavin
    Zhang, Annie
    Hotermans, Christophe
    Stephan, Monica
    Dawson, Katherine
    Bar-Or, Amit
    NEUROLOGY, 2013, 80
  • [27] Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study
    Kappos, Ludwig
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Sarda, Sujata P.
    Agarwal, Sonalee
    Zhang, Annie
    Sheikh, Sarah I.
    Seidman, Emily
    Dawson, Katherine T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (02) : 243 - 252
  • [28] An integrated analysis of the clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis from the phase 3 DEFINE and CONFIRM studies
    Fox, R. J.
    Miller, D. H.
    Phillips, J. T.
    Arnold, D. L.
    Selmaj, K.
    Yang, M.
    Zhang, R.
    Dawson, K. T.
    Viglietta, V.
    Sheikh, S. I.
    Gold, R.
    JOURNAL OF NEUROLOGY, 2013, 260 : S74 - S74
  • [29] Effects of BG-12 on Magnetic Resonance Imaging (MRI) Endpoints in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Data From the Phase 3 CONFIRM Study
    Miller, David
    Fox, Robert
    Phillips, J. Theodore
    Kita, Mariko
    Hutchinson, Michael
    Havrdova, Eva
    Zhang, Ray
    Viglietta, Vissia
    Dawson, Katherine
    NEUROLOGY, 2012, 78
  • [30] Effect of BG-12 (Dimethyl Fumarate) in Subgroups of Patients with Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Bar-Or, Amit
    Fox, Robert
    Gold, Ralf
    Miller, David
    Arnold, Douglas
    O'Gorman, John
    Yang, Minhua
    Sheikh, Sarah
    Viglietta, Vissia
    Dawson, Katherine
    Hutchinson, Michael
    NEUROLOGY, 2013, 80
12345